Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-251395 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 1, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
18,000
Total Value
$156,060.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | May 29, 2026 | Exercise/Conversion | 6,000 | $6.14 | $36,840.00 | 73,845 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | May 29, 2026 | Sale | 6,000 | $19.87 | $119,220.00 | 67,845 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | May 29, 2026 | Exercise/Conversion | 6,000 | $0.00 | $0.00 | 209,290 | Direct | โ | View Details |